Effect of splint in trigger finger

The comparison between finger-based relative motion extension splint and hand-based splint in the improvement of pain, range of motion, pinch strength, gross motor function of the hand, fine motor function of the hand and functional status of the patients with trigger finger

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250915067248N1

Enrollment

Registered

2025-09-29

Start date

2025-11-06

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger finger.

Interventions

Intervention 1: Intervention group: This group receives a Relative Motion Extension splint made of Orficast, in which the trigger finger is placed in 15 to 20 degrees of extension relative to the adja

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: A person with trigger finger grade one, two, and three based on the GREEN classification system Be between 18-60 years old No trigger finger disorder in multiple fingers on one hand No trigger thumb. Individuals must give full consent to participate in the study. No corticosteroid injection in the affected hand in the last 6 months No trigger release surgery No triggering in the third annular pully Absence of musculoskeletal problems and continuous injury in the affected hand Absence of diabetes mellitus and rheumatoid arthritis No history of trigger finger in the past Not using other treatments at the same time Failure to use splints continuously during immobilization and not using other splints for any reason

Exclusion criteria

Exclusion criteria: Unwillingness to continue cooperation by the patient at any time for any reason Having any re-trauma after using a splint during the treatment period

Design outcomes

Primary

Measure	Time frame
Pain, total range of finger flexion, pinch strength, upper limb functional status, gross motor function of the hand, fine motor function of the hand, trigger finger degree. Timepoint: All variables will be measured in three stages: initial assessment, i.e. before the start of the intervention, secondary assessment, i.e. 6 weeks after the intervention, and tertiary assessment, i.e. follow-up treatment, one month after the secondary assessment. Method of measurement: A digital pinch gauge will be used to measure pinch strength. A visual pain scale will be used to determine the pain level of the study participants. The total range of finger flexion will be measured using a goniometer. The severity of trigger finger will be determined using the GREEN classification system. The functional status of the upper limb will be measured using the QUICK-DASH questionnaire. Gross motor function will be measured using the Box and Block tool, and fine motor function will be measured using the Nine Hole Peg Test tool.	—

Measure

Time frame

Pain, total range of finger flexion, pinch strength, upper limb functional status, gross motor function of the hand, fine motor function of the hand, trigger finger degree. Timepoint: All variables will be measured in three stages: initial assessment, i.e. before the start of the intervention, secondary assessment, i.e. 6 weeks after the intervention, and tertiary assessment, i.e. follow-up treatment, one month after the secondary assessment. Method of measurement: A digital pinch gauge will be used to measure pinch strength. A visual pain scale will be used to determine the pain level of the study participants. The total range of finger flexion will be measured using a goniometer. The severity of trigger finger will be determined using the GREEN classification system. The functional status of the upper limb will be measured using the QUICK-DASH questionnaire. Gross motor function will be measured using the Box and Block tool, and fine motor function will be measured using the Nine Hole Peg Test tool.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSana Khalili

Shahid Beheshti University of Medical Sciences

skhalili462@gmail.com+98 21 4444 7174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026